Remote Monitored Systems General Meeting 12th Feb 2021 at Pharm2Farm Ltd

Remote Monitored Systems

Remote Monitored Systems plc (LON:RMS) today advised that a shareholder circular convening a general meeting of the Company has been posted to shareholders and will shortly be available on the Company’s website at: www.remotemonitoredsystems.com. 

The Company is requesting approval for, inter alia, the issue of the Placing Warrants and Broker Warrants in connection with the Company’s Placing, announced on 18 December 2020.

The General Meeting will be held at 1:00 p.m. on 12 February 2021 at the offices of Pharm2Farm Ltd, BioCity Nottingham, Pennyfoot Street, Nottingham NG1 1GF, United Kingdom.

In light of the ongoing Covid-19 pandemic and with a view to taking appropriate measures to safeguard its Shareholders health and make the General Meeting as safe and efficient as possible, the Company is invoking certain of the meetings provisions in the Act and its Articles. For the purposes of the provisions of the Articles, Remote Monitored Systems is designating the location of the meeting to be the place where the Chairman is located.  Please note, however, that voting will only be able to take place by proxy. No Shareholder will be allowed entry into the meeting.

Shareholders will be able to submit questions by emailing [email protected] ahead of the General Meeting. Only questions in relation to the Resolutions or business of the General Meeting will be considered.

Unless otherwise indicated, all defined terms in this announcement shall have the same meaning as described in the Circular.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

    JPMorgan European Discovery Trust reports strong performance uplift in latest factsheet

    JPMorgan European Discovery Trust reported a 5.37% share price rise in July 2025, outpacing NAV and its benchmark. Year-to-date, the share price is up 34.17%, supported by strong small-cap performance and effective stock selection.

    Golden Matrix reports record August revenue of $17.8m, up 18% year-on-year

    Golden Matrix posted record August revenues of $17.8m, up 18% from last year, with July revenues also rising 24% to $15.7m. Strong performance came from Meridianbet’s sports betting and RKings’ tournaments, positioning the group for record Q3 results.

    HUTCHMED to present new lung cancer and oncology data at WCLC and CSCO 2025

    HUTCHMED announced that updated data on savolitinib in NSCLC and other pipeline compounds will be presented at the World Conference on Lung Cancer in Barcelona and the CSCO Annual Meeting in China this September. Presentations include studies on savolitinib, surufatinib, fruquintinib and first-in-human results for HMPL-653.

    Surface Transforms appoints Paul Marr as Non-Executive Director

    Surface Transforms has appointed Paul Marr to its Board as Non-Executive Director. Marr brings over 40 years of global automotive manufacturing and operational leadership experience, including senior roles at General Motors and other international groups.

    Avation signs 12-year lease for ATR 72-600 with Cambodian airline

    Avation has agreed a twelve-year lease with a Cambodian carrier for a new ATR 72-600, the second of ten aircraft ordered in 2024. Delivery is scheduled for February 2026.

    Tern Plc delivers stronger interim results with reduced loss and portfolio growth

    Tern Plc reported improved interim results for the six months to 30 June 2025, with a 64% reduction in loss, disciplined cost control, and a new strategic investment in Sure Ventures plc. The company also strengthened portfolio support through successful fundraises.

      Search

      Search